Yes, .10 is no joke nor a dream for a future stock price, with as many or more shares. When the future of so many products for so many ailments is understood by the investment world and the FDA clearances come routinely, eyes will open wide to how powerful this could all turn out to be. Evaluating stock price at .10 gives us a market cap of 1.8 billion. Not ridiculous at all if the market sees the immense potential of this company and its present products AND future products for more physiological uses. Just of what we now have cleared (foot and knee) and the ones in the FDA review file (migraine and back (full muscle and joint pain)), if cleared, I can see us getting into the pennies easily. Now comes serious conjecture on buyouts and or partnering or more licensing deals and it is IMO definitely not far fetched to see a price of .10. In fact, if ALL goes according to what I envision, we are passing that number easily from emotion and excitement for what is possible in the future for this company and its products.
News 
Market Data 
Discover 
AI
